Browse Articles

Filter By:

  • This Review discusses the different mechanisms of antibody-dependent enhancement (ADE) of infectious disease, including how antibodies can increase the pathogen load, protect bacteria from the immune system and amplify inflammation. The authors also highlight the role of autoantibodies and consider how a better understanding of ADE can be used to improve vaccines and treatments for infectious diseases.

    • Timothy J. Wells
    • Tyron Esposito
    • Larisa I. Labzin
    Review Article
  • Neuroinflammation in response to infection or chronic disease can cause non-neural symptoms such as fatigue and muscle pain. Yang et al. show that CNS-derived IL-6 directly regulates muscle physiology.

    • Alexandra Flemming
    Research Highlight
  • Transient depletion of the gut microbiome by antibiotics in early life reduces systemic levels of the metabolite indole-3-propionic acid, which causes long-lasting mitochondrial damage to lung epithelial cells and increases susceptibility to airway inflammation in adult mice.

    • Lucy Bird
    Research Highlight
  • In this Tools of the Trade article, Camilla Engblom and colleagues describe their elegant technique ‘Spatial VDJ’ to detect and map antigen receptor sequences in human tissue sections.

    • Qirong Lin
    • Kim Thrane
    • Camilla Engblom
    Tools of the Trade
  • This Review covers recent advances in our understanding of CD28 co-stimulation of T cells and discusses an emerging paradigm that positions CD28 as central to the success of current and future immunotherapeutic approaches to treating cancer.

    • Michael T. Lotze
    • Scott H. Olejniczak
    • Dimitris Skokos
    Review Article
  • Here, Raffatellu and co-workers discuss our growing understanding of how primary bile acids (which are cholesterol-derived molecules synthesized in the liver) and secondary bile acids (which are primary bile acids that have been microbially modified) shape immune responses in health and disease, with a particular focus on bile acids and intestinal immunity.

    • Michael H. Lee
    • Sean-Paul Nuccio
    • Manuela Raffatellu
    Review Article
  • Age-associated defects in dendritic cells can be corrected by hyperactivating adjuvants containing an oxidized phospholipid to induce effective antitumour responses in mice.

    • Lucy Bird
    Research Highlight
  • Two papers in Nature Immunology provide a comprehensive atlas of human natural killer cells in health and in different types of cancer.

    • Alexandra Flemming
    Research Highlight
  • In this Comment article, organizers of the International School of Immunotherapy (Immunoschool) reflect on the experience gained from the past ten years in using online technologies for global and inclusive immunology education.

    • Nicolas Vabret
    • Jaime Mateus-Tique
    • Miriam Merad
    Comment
  • This Review by Arnold and Munitz discusses the diverse roles of eosinophils in the settings of tissue homeostasis, infection, allergy and cancer. The authors explain the molecular mechanisms that enable eosinophils to adapt to diverse tissue types and conditions, and they consider the therapeutic potential of eosinophil-depleting drugs in the clinic.

    • Isabelle C. Arnold
    • Ariel Munitz
    Review Article
  • In this Viewpoint, Nature Reviews Immunology invites eight experts in the field to share their thoughts on the key questions and challenges in MDSC research.

    • Leila Akkari
    • Ido Amit
    • Suzanne Ostrand-Rosenberg
    Viewpoint
  • A preprint by Ngo et al. reports a new mouse model for the constitutive depletion of pDCs, showing that pDCs are dispensable for antiviral immunity.

    • Ester Gea-Mallorquí
    • Sarah Rowland-Jones
    Journal Club
  • An adoptive cellular therapy based on γδ T cells, which were engineered to secrete a tumour-targeting opsonin as well as an IL-15 superagonist, controlled tumour growth in a mouse model of patient-derived osteosarcoma.

    • Alexandra Flemming
    Research Highlight
  • A study by Nakayama et al. shows that heart failure causes epigenetic changes in haematopoietic stem cells that predispose to further heart disease and comorbidity.

    • Alexandra Flemming
    Research Highlight